ABSTRACT
Objective To analyze the curative effect of blood transfusion on 100 patients undergoing liver transplantation,to efficiently enhance hemostasis and coagulation function of the patients,to lower the incidence of the operative complications,and to put forward the guideline of blood transfusion to the patients undergoing liver transplantation.Methods The volumes of red blood cells concentrates(RCCs),fresh frozen plasma(FFP),cryopreserved platelets,and cryoprecipitate transfused to the patients undergoing liver transplantation were measured before,during and after the operation respectively.The volumes of blood components transfused to the 50 patients in the former stage and 50 patients in the later stage of liver transplantation in our hospital were also measured respectively.Results The mean volume of the blood components transfused to each patient was 3 334ml.The ratios of the transfused blood volumes to 100 patients were 4.3%,53.4% and 42.3% before,during and after operation respectively.The rate of blood components transfusion was 100% and the ratio of transfused blood volumes to the patients between RCCs and FFP was 1.45:1.The mean volumes of the transfused blood and the operative complications of 50 patients in the former stage of liver transplantation of our hospital were significantly higher than those of the 50 patients in the later stage.Conclusion It is very vital in the scientific,safe and reasonable blood transfusion for the success of liver transplantation,which significantly lowers the incidence of operative complications,such as massive haemorrhage during and after operation,and thrombosis at inosculation of liver artery and portal vein.
ABSTRACT
Objective To study the changes of CPDA whole blood's shelf life after stored at non-4℃. Methods 200 ml whole blood was collected from each of 10 donors and anticoagulated by CPDA. Then 50 ml whole blood from each one was marked as control group, the rest was marked as test group. The blood of the control group was stored at 4℃ and RBC ATP concentration at the end of its shelf life served as critical ATP. The blood of the test group was stored at 10℃ for 24 hours, then it was transferred to 4℃ refrigeratory and continued to preserve. RBC ATP concentration were tested daily to ensure it eligible. When RBC ATP concentration decreased to the level of critical ATP, the time of preservation at 4℃ was blood's succeeding shelf life. Using the same method, the succeeding shelf life of CPDA whole blood after stored at different temperature for 48 to 72 hours was measured. Results The succeeding shelf life of CPDA whole blood did not obviously change after stored at non-4℃ for 24 hours, while it shortened dramaticly after stored at non-4℃ for more than 48 hours. The higher the temperature, the shorter the succeeding shelf life. Conclusion The results suggested that CPDA whole blood's succeeding shelf life should be adjusted after stored at non-4℃ for 24 to 72 hours to ensure the blood quality.